Could stem cells be the key to saving lives from Sepsis-Induced lung failure?
NCT ID NCT07439848
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether adding umbilical cord stem cells or their secretions to standard care can help people with severe lung injury (ARDS) caused by pneumonia-related sepsis. The goal is to see if these treatments can shorten hospital stays and lower the risk of death. The trial is in early phases and will enroll 15 adults aged 40 and older.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
RSPAD Gatot Soebroto
RECRUITINGJakarta Pusat, DKI Jakarta, 10410, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Lung-Opening maneuver change a key injury marker in ARDS?
- Could simply sitting up ease breathing in severe lung failure?
- Could lung fluid proteins reveal a new way to track severe lung injury?
- Could a spirometer test guide breathing support in respiratory failure?
- Which ventilator setting saves more lungs? a Head-to-Head test
- Can a single antibody turn down the immune storm in ARDS?